CPAMD8
Basic information
Region (hg38): 19:16892951-17026815
Links
Phenotypes
GenCC
Source:
- anterior segment dysgenesis 8 (Strong), mode of inheritance: AR
- anterior segment dysgenesis 8 (Moderate), mode of inheritance: AR
- anterior segment dysgenesis 8 (Strong), mode of inheritance: AR
- anterior segment dysgenesis 8 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Anterior segement dysgenesis 8 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 27839872 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (6 variants)
- Anterior segment dysgenesis 8 (1 variants)
- Glaucoma 3A (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CPAMD8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 49 | 27 | 76 | |||
missense | 165 | 23 | 37 | 225 | ||
nonsense | 5 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 2 | 7 | 8 | 17 | ||
non coding | 14 | 14 | 82 | 113 | ||
Total | 7 | 9 | 180 | 86 | 146 |
Highest pathogenic variant AF is 0.000131
Variants in CPAMD8
This is a list of pathogenic ClinVar variants found in the CPAMD8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-16892978-T-G | Benign (May 10, 2021) | |||
19-16893128-T-C | Benign/Likely benign (Aug 11, 2023) | |||
19-16893179-C-T | Inborn genetic diseases | Likely benign (Sep 15, 2021) | ||
19-16893187-G-A | Inborn genetic diseases | Likely benign (Mar 14, 2023) | ||
19-16893221-C-A | Uncertain significance (Aug 05, 2022) | |||
19-16893223-C-T | Inborn genetic diseases | Uncertain significance (Oct 22, 2021) | ||
19-16893230-T-C | Inborn genetic diseases | Uncertain significance (Oct 05, 2023) | ||
19-16893238-T-C | Benign (Jan 29, 2024) | |||
19-16893245-C-T | Uncertain significance (Nov 02, 2022) | |||
19-16893247-G-A | Inborn genetic diseases | Likely benign (May 23, 2024) | ||
19-16893305-C-T | See cases • Inborn genetic diseases | Uncertain significance (Sep 09, 2022) | ||
19-16893308-T-C | Inborn genetic diseases | Uncertain significance (Aug 01, 2022) | ||
19-16893323-G-A | Inborn genetic diseases | Uncertain significance (Sep 16, 2021) | ||
19-16895976-G-A | Benign (May 10, 2021) | |||
19-16896136-A-C | Benign (May 11, 2021) | |||
19-16896219-C-T | Inborn genetic diseases | Uncertain significance (Jul 19, 2023) | ||
19-16896253-C-T | CPAMD8-related disorder | Benign (Dec 05, 2023) | ||
19-16896260-G-C | CPAMD8-related disorder | Benign (Mar 18, 2022) | ||
19-16896267-G-A | Inborn genetic diseases | Uncertain significance (Dec 17, 2023) | ||
19-16896296-G-A | Inborn genetic diseases | Uncertain significance (Aug 16, 2022) | ||
19-16896339-G-A | Benign (Nov 13, 2023) | |||
19-16896346-G-A | Likely benign (Aug 22, 2022) | |||
19-16896503-C-A | Inborn genetic diseases | Uncertain significance (May 23, 2024) | ||
19-16896552-C-T | Benign (Jan 11, 2024) | |||
19-16896565-C-G | Benign (Mar 19, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CPAMD8 | protein_coding | protein_coding | ENST00000443236 | 42 | 133868 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.92e-23 | 1.00 | 124613 | 0 | 228 | 124841 | 0.000914 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.167 | 1094 | 1.11e+3 | 0.986 | 0.0000678 | 12339 |
Missense in Polyphen | 351 | 380.27 | 0.92303 | 4496 | ||
Synonymous | 0.213 | 471 | 477 | 0.988 | 0.0000322 | 3977 |
Loss of Function | 4.27 | 53 | 98.8 | 0.536 | 0.00000537 | 1030 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00130 | 0.00129 |
Ashkenazi Jewish | 0.000201 | 0.000199 |
East Asian | 0.00106 | 0.00106 |
Finnish | 0.000233 | 0.000232 |
European (Non-Finnish) | 0.00127 | 0.00124 |
Middle Eastern | 0.00106 | 0.00106 |
South Asian | 0.000691 | 0.000686 |
Other | 0.000829 | 0.000824 |
dbNSFP
Source:
- Disease
- DISEASE: Anterior segment dysgenesis 8 (ASGD8) [MIM:617319]: A form of anterior segment dysgenesis, a group of defects affecting anterior structures of the eye including cornea, iris, lens, trabecular meshwork, and Schlemm canal. Anterior segment dysgeneses result from abnormal migration or differentiation of the neural crest derived mesenchymal cells that give rise to components of the anterior chamber during eye development. Different anterior segment anomalies may exist alone or in combination, including iris hypoplasia, enlarged or reduced corneal diameter, corneal vascularization and opacity, posterior embryotoxon, corectopia, polycoria, abnormal iridocorneal angle, ectopia lentis, and anterior synechiae between the iris and posterior corneal surface. Clinical conditions falling within the phenotypic spectrum of anterior segment dysgeneses include aniridia, Axenfeld anomaly, Reiger anomaly/syndrome, Peters anomaly, and iridogoniodysgenesis. ASGD8 patients predominantly manifest iris and lens abnormalities, in the absence of retinal abnormalities or extra-ocular features. ASGD8 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:27839872}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.912
- rvis_EVS
- 2.44
- rvis_percentile_EVS
- 98.55
Haploinsufficiency Scores
- pHI
- 0.103
- hipred
- N
- hipred_score
- 0.436
- ghis
- 0.416
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.696
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Vip
- Phenotype
- immune system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- eye development;negative regulation of endopeptidase activity
- Cellular component
- extracellular space;plasma membrane
- Molecular function
- serine-type endopeptidase inhibitor activity